Gabapentin Tablet, Coated
Product Images NDC 50268-325

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50268-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (325 15)

The packaging label for Gabapentin Tablets, USP 600 mg by AvPAK. It includes the NDC 50268-325-15 and indicates the oral coated tablet dosage form. The label specifies 50 tablets (5 x 10 unit dose) and cautions for prescription use only. Storage instructions and manufacturer information are also shown.*

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure of Gabapentin showing a cyclohexane ring attached to side chains including an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

FDA Label Image

Figure 1 (Gabapenin 02)

Line graph depicting mean pain score over an 8-week period comparing placebo and Gabapentin 3,600 mg/day. The graph shows a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin demonstrating a gradual decrease in mean pain score compared to placebo.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph depicting mean pain scores over a 7-week period comparing placebo to Gabapentin at dosages of 1,800 mg/day and 2,400 mg/day. The x-axis represents weeks, with a 3-week dose titration period followed by a 4-week fixed dose period, while the y-axis shows mean pain scores ranging from 0 to 10. Both Gabapentin doses show a more pronounced decrease in mean pain score compared to placebo over time.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart comparing percentage values across two studies. Study 1 shows two bars for PBO at 12% and GBP 3,600 at 29%. Study 2 shows three bars for PBO at 14%, GBP 1,800 at 32%, and GBP 2,400 at 34%. Statistical significance is indicated with asterisks for p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapenin 05)

A scatter plot showing the percentage difference versus daily dose (mg) with data points labeled from three studies (a, b, c). The daily dose ranges from 600 mg to 1800 mg, with differences varying between approximately 2% and 22%. The chart compares outcomes across Study a, Study b, and Study c.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.